Shield Therapeutics plc (AIM: STX)

Shield Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.1	13.95	3.4	12.12	2.94	4.14
Cash & Short-Term Investments	8.1	13.95	3.4	12.12	2.94	4.14
Cash Growth	-40.42%	309.99%	-71.92%	312.14%	-29.00%	-57.64%
Accounts Receivable	15.41	9.99	3.39	0.82	0.22	-
Other Receivables	0.3	1.23	1.13	0.96	0.44	1.15
Receivables	15.7	11.21	4.52	1.77	0.66	1.15
Inventory	4.04	3.2	1.76	1.64	1.38	0.95
Prepaid Expenses	-	2.9	2.5	1.73	0.26	0.16
Total Current Assets	27.84	31.26	12.17	17.26	5.23	6.4
Property, Plant & Equipment	0.52	0.67	0.24	0.3	0.03	0.03
Other Intangible Assets	19.35	1.18	1.23	17.32	18.83	20.94
Long-Term Deferred Charges	-1.94	15.68	12.98	9.53	8.43	8.96
Total Assets	46.76	48.8	26.62	44.41	32.53	36.32
Accounts Payable	19.36	4.05	1.74	1.31	0.4	2.67
Accrued Expenses	-	8.67	9.71	2.14	1.08	0.88
Current Portion of Leases	0.29	0.21	0.11	0.16	0.03	0.02
Current Income Taxes Payable	-	0.1	0.27	0.05	0.67	0.55
Other Current Liabilities	6.89	0.7	1.01	0.06	0.08	0.05
Total Current Liabilities	26.54	13.74	12.83	3.72	2.25	4.17
Long-Term Debt	19.68	19.84	6.68	-	-	-
Long-Term Leases	-	0.2	-	-	-	-
Other Long-Term Liabilities	-	-	0.56	-	-	-
Total Liabilities	46.22	33.77	20.07	3.72	2.25	4.17
Common Stock	15.01	15.01	5.37	3.24	1.76	1.76
Additional Paid-In Capital	198.76	198.76	169.48	114.58	88.35	88.35
Retained Earnings	-248.42	-233.53	-201.11	-106.94	-88.25	-86.39
Comprensive Income & Other	35.19	34.79	32.8	29.81	28.41	28.43
Total Common Equity	0.54	15.03	6.54	40.69	30.28	32.15
Shareholders' Equity	0.54	15.03	6.54	40.69	30.28	32.15
Total Liabilities & Equity	46.76	48.8	26.62	44.41	32.53	36.32
Total Debt	19.97	20.25	6.79	0.16	0.03	0.02
Net Cash (Debt)	-11.87	-6.3	-3.39	11.96	2.91	4.12
Net Cash Growth	-	-	-	310.75%	-29.34%	-57.20%
Net Cash Per Share	-0.02	-0.01	-0.01	0.06	0.02	0.04
Filing Date Shares Outstanding	782.06	782.06	259.39	215.89	117.62	117.19
Total Common Shares Outstanding	782.06	782.06	259.39	215.89	117.62	117.19
Working Capital	1.3	17.53	-0.66	13.54	2.98	2.22
Book Value Per Share	0.00	0.02	0.03	0.19	0.26	0.27
Tangible Book Value	-18.8	13.85	5.31	23.37	11.44	11.21
Tangible Book Value Per Share	-0.02	0.02	0.02	0.11	0.10	0.10
Machinery	-	0.48	0.24	0.2	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.